Dr. Alissa Thomas
Claim this profileUniversity of Vermont Medical Center
Area of expertise
Glioblastoma
Alissa Thomas has run 6 trials for Glioblastoma. Some of their research focus areas include:
Brain Tumor
Alissa Thomas has run 3 trials for Brain Tumor. Some of their research focus areas include:
Affiliated Hospitals
University Of Vermont Medical Center
Central Vermont Medical Center/National Life Cancer Treatment
Clinical Trials Alissa Thomas is currently running
Multiple Targeted Therapies
for Meningioma
This trial studies four drugs to treat patients with worsening meningioma. These drugs work by blocking enzymes that the tumor cells need to grow. The trial focuses on patients whose tumors have specific genetic mutations.
Recruiting
1 award
Phase 2
10 criteria
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to standard chemotherapy with temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. MGMT methylated tumors are more likely to respond to temozolomide chemotherapy. Temozolomide is in a class of medications called alkylating agents. It works by damaging the cell's DNA and may kill tumor cells and slow down or stop tumor growth. Lomustine is a chemotherapy drug and in a class of medications called alkylating agents. It damages the cell's DNA and may kill tumor cells. Radiation therapy uses high energy x-ray photons to kill tumor cells and shrink tumors. Adding lomustine to standard chemotherapy with temozolomide and radiation therapy may shrink or stabilize glioblastoma.
Recruiting
2 awards
Phase 3
4 criteria
More about Alissa Thomas
Clinical Trial Related
4 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Alissa Thomas has experience with
- Nivolumab
- Abemaciclib
- Lomustine
- Tirabrutinib
- Bevacizumab
- Re-irradiation (RT)
Breakdown of trials Alissa Thomas has run
Glioblastoma
Brain Tumor
Gliosarcoma
Central Nervous System Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alissa Thomas specialize in?
Alissa Thomas focuses on Glioblastoma and Brain Tumor. In particular, much of their work with Glioblastoma has involved IDH negative patients, or patients who are MET positive.
Is Alissa Thomas currently recruiting for clinical trials?
Yes, Alissa Thomas is currently recruiting for 3 clinical trials in Burlington Vermont. If you're interested in participating, you should apply.
Are there any treatments that Alissa Thomas has studied deeply?
Yes, Alissa Thomas has studied treatments such as Nivolumab, Abemaciclib, Lomustine.
What is the best way to schedule an appointment with Alissa Thomas?
Apply for one of the trials that Alissa Thomas is conducting.
What is the office address of Alissa Thomas?
The office of Alissa Thomas is located at: University of Vermont Medical Center, Burlington, Vermont 05401 United States. This is the address for their practice at the University of Vermont Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.